Company Filing History:
Years Active: 1993
Title: Kathryn L Strauch: Innovator in Thrombin Inhibition
Introduction
Kathryn L Strauch is a notable inventor based in Newton, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of novel therapeutic agents. Her work focuses on creating innovative solutions for thrombotic diseases.
Latest Patents
Kathryn L Strauch holds 1 patent for her invention titled "Bifunctional inhibitors of thrombin and platelet activation." This invention relates to novel bifunctional inhibitors that target both platelet activation and thrombin. These inhibitors are characterized by two distinct domains: a glycoprotein IIb/IIIa inhibitory domain and a thrombin inhibitory domain. The invention also encompasses DNA sequences that encode these bifunctional inhibitors, recombinant DNA molecules containing these sequences, and hosts transformed with these DNA molecules. Furthermore, it details methods for purifying the recombinant bifunctional inhibitors and provides compositions that may be useful in treating thrombotic diseases.
Career Highlights
Kathryn is associated with Biogen, Incorporated, where she applies her expertise in biochemistry to advance medical research and therapeutic development. Her innovative work has the potential to significantly impact patient care by improving treatment options for thrombotic conditions.
Collaborations
Throughout her career, Kathryn has collaborated with esteemed colleagues, including John M Maraganore and Betty H Chao. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Kathryn L Strauch is a pioneering inventor whose work in thrombin inhibition represents a significant advancement in medical science. Her contributions continue to influence the field and offer hope for improved treatments for thrombotic diseases.